Calico drops to #26; senolytics discussed
Calico falls from #1 to #26 in the Eternal Search company rating as the Rejuvenation Science News group discusses senolytics and cellular senescence.
Rejuvenation Science News is discussing senolytics: they target cellular senescence, but can they actually slow aging?
The Eternal Search company rating saw major moves this week. Top five: GlycanAge (45.2), HCW Biologics (41.5), Minovia (39.9), Cyclarity Therapeutics (37.1), Intervene Immune (35.4). Calico dropped from #1 to #26; Immunis fell from #10 to #30. Biggest climbers: HexemBio (+33 spots), Agemica, Healome, and Focal Biosciences (+32 each).
Cellular senescence, Eternal Search glossary
Sources
Senolytics and their potential to slow aging - Facebook
Senolytics are among the most discussed topics in public longevity communities, yet the Eternal Search multi-dimensional company rating contains zero senolytic-focused companies in the top 50. This gap between discussion volume and rated substance is a concrete, checkable finding that directs readers to the cellular senescence glossary page to understand the biology these companies target.